Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1911 | 5888 | 47.0 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
269 | 3 | CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE | 44007 |
1911 | 2 | FARNESYLTRANSFERASE//RAS//RAL | 5888 |
2877 | 1 | FARNESYLTRANSFERASE//FARNESYLTRANSFERASE INHIBITOR//PROTEIN FARNESYLTRANSFERASE | 2125 |
4031 | 1 | RAS//RAS PROTEINS//ONCOGENIC RAS P21 | 1860 |
11178 | 1 | RAP1//EPAC//EPAC1 | 1002 |
14252 | 1 | RAL//EXOCYST//RLIP76 | 781 |
33764 | 1 | FARNESYLTHIOSALICYLIC ACID//SALIRASIB//FTS | 120 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FARNESYLTRANSFERASE | authKW | 382557 | 2% | 65% | 113 |
2 | RAS | authKW | 369612 | 8% | 15% | 490 |
3 | RAL | authKW | 207907 | 1% | 70% | 57 |
4 | FARNESYLTRANSFERASE INHIBITOR | authKW | 205028 | 1% | 67% | 59 |
5 | RAP1 | authKW | 180532 | 2% | 36% | 97 |
6 | EXOCYST | authKW | 176296 | 1% | 55% | 62 |
7 | RLIP76 | authKW | 171402 | 1% | 85% | 39 |
8 | RAS PROTEINS | authKW | 161242 | 1% | 45% | 69 |
9 | EPAC | authKW | 155762 | 1% | 43% | 70 |
10 | PROTEIN FARNESYLTRANSFERASE | authKW | 141126 | 1% | 83% | 33 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 22294 | 51% | 0% | 3015 |
2 | Cell Biology | 15844 | 27% | 0% | 1618 |
3 | Oncology | 4174 | 16% | 0% | 913 |
4 | Chemistry, Medicinal | 2951 | 7% | 0% | 431 |
5 | Biophysics | 1950 | 8% | 0% | 448 |
6 | Biochemical Research Methods | 512 | 4% | 0% | 240 |
7 | Genetics & Heredity | 462 | 5% | 0% | 303 |
8 | Chemistry, Organic | 345 | 5% | 0% | 305 |
9 | Hematology | 213 | 3% | 0% | 158 |
10 | Pharmacology & Pharmacy | 83 | 5% | 0% | 298 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT STRUKTURELLE BIOL | 55505 | 1% | 36% | 30 |
2 | KENTUCKY STRUCT BIOL | 48314 | 0% | 55% | 17 |
3 | ABT STRUKT BIOL | 22606 | 0% | 36% | 12 |
4 | DENT ORAL MAXILLO IAL SURG PLAST RECON | 20736 | 0% | 100% | 4 |
5 | BIOMED GENET | 20250 | 1% | 5% | 75 |
6 | MED CELL BIOL PHARMACOL | 18658 | 0% | 60% | 6 |
7 | INTEGRAT BIOL PHARMACOL | 16908 | 1% | 6% | 51 |
8 | NEUROBIOCHEM | 16616 | 1% | 7% | 49 |
9 | LEHRSTUHL BIOPHYS | 16255 | 0% | 14% | 22 |
10 | MOL BIOLCHUO KU | 16211 | 0% | 26% | 12 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL CHEMISTRY | 12224 | 10% | 0% | 614 |
2 | MOLECULAR AND CELLULAR BIOLOGY | 9880 | 4% | 1% | 209 |
3 | ONCOGENE | 9144 | 3% | 1% | 181 |
4 | METHODS IN ENZYMOLOGY | 3735 | 2% | 1% | 111 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3532 | 2% | 1% | 135 |
6 | CELLULAR SIGNALLING | 3506 | 1% | 1% | 55 |
7 | BIOCHEMISTRY | 3142 | 3% | 0% | 188 |
8 | MOLECULAR BIOLOGY OF THE CELL | 2846 | 1% | 1% | 69 |
9 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1637 | 3% | 0% | 188 |
10 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1421 | 2% | 0% | 147 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FARNESYLTRANSFERASE | 382557 | 2% | 65% | 113 | Search FARNESYLTRANSFERASE | Search FARNESYLTRANSFERASE |
2 | RAS | 369612 | 8% | 15% | 490 | Search RAS | Search RAS |
3 | RAL | 207907 | 1% | 70% | 57 | Search RAL | Search RAL |
4 | FARNESYLTRANSFERASE INHIBITOR | 205028 | 1% | 67% | 59 | Search FARNESYLTRANSFERASE+INHIBITOR | Search FARNESYLTRANSFERASE+INHIBITOR |
5 | RAP1 | 180532 | 2% | 36% | 97 | Search RAP1 | Search RAP1 |
6 | EXOCYST | 176296 | 1% | 55% | 62 | Search EXOCYST | Search EXOCYST |
7 | RLIP76 | 171402 | 1% | 85% | 39 | Search RLIP76 | Search RLIP76 |
8 | RAS PROTEINS | 161242 | 1% | 45% | 69 | Search RAS+PROTEINS | Search RAS+PROTEINS |
9 | EPAC | 155762 | 1% | 43% | 70 | Search EPAC | Search EPAC |
10 | PROTEIN FARNESYLTRANSFERASE | 141126 | 1% | 83% | 33 | Search PROTEIN+FARNESYLTRANSFERASE | Search PROTEIN+FARNESYLTRANSFERASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LU, SY , JANG, H , MURATCIOGLU, S , GURSOY, A , KESKIN, O , NUSSINOV, R , ZHANG, J , (2016) RAS CONFORMATIONAL ENSEMBLES, ALLOSTERY, AND SIGNALING.CHEMICAL REVIEWS. VOL. 116. ISSUE 11. P. 6607 -6665 | 256 | 62% | 5 |
2 | SOUSA, SF , FERNANDES, PA , RAMOS, MJ , (2008) FARNESYLTRANSFERASE INHIBITORS: A DETAILED CHEMICAL VIEW ON AN ELUSIVE BIOLOGICAL PROBLEM.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 15. P. 1478-1492 | 193 | 86% | 70 |
3 | ZHANG, FL , CASEY, PJ , (1996) PROTEIN PRENYLATION: MOLECULAR MECHANISMS AND FUNCTIONAL CONSEQUENCES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 65. ISSUE . P. 241-269 | 147 | 74% | 1329 |
4 | BERNDT, N , HAMILTON, AD , SEBTI, SM , (2011) TARGETING PROTEIN PRENYLATION FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 11. ISSUE 11. P. 775 -791 | 138 | 64% | 163 |
5 | MOORTHY, NSHN , SOUSA, SF , RAMOS, MJ , FERNANDES, PA , (2013) FARNESYLTRANSFERASE INHIBITORS: A COMPREHENSIVE REVIEW BASED ON QUANTITATIVE STRUCTURAL ANALYSIS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 38. P. 4888-4923 | 164 | 74% | 9 |
6 | BENETKA, W , KORANDA, M , EISENHABER, F , (2006) PROTEIN PRENYLATION: AN (ALMOST) COMPREHENSIVE OVERVIEW ON DISCOVERY HISTORY, ENZYMOLOGY, AND SIGNIFICANCE IN PHYSIOLOGY AND DISEASE.MONATSHEFTE FUR CHEMIE. VOL. 137. ISSUE 10. P. 1241 -1281 | 230 | 63% | 17 |
7 | AYRAL-KALOUSTIAN, S , SALASKI, EJ , (2002) PROTEIN FARNESYLTRANSFERASE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 10. P. 1003 -1032 | 191 | 81% | 35 |
8 | LU, SY , JANG, H , GU, S , ZHANG, J , NUSSINOV, R , (2016) DRUGGING RAS GTPASE: A COMPREHENSIVE MECHANISTIC AND SIGNALING STRUCTURAL VIEW.CHEMICAL SOCIETY REVIEWS. VOL. 45. ISSUE 18. P. 4929 -4952 | 141 | 64% | 3 |
9 | PRAKASH, P , GORFE, AA , (2013) LESSONS FROM COMPUTER SIMULATIONS OF RAS PROTEINS IN SOLUTION AND IN MEMBRANE.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1830. ISSUE 11. P. 5211-5218 | 124 | 83% | 13 |
10 | GIBBS, RA , ZAHN, TJ , SEBOLT-LEOPOLD, JS , (2001) NON-PEPTIDIC PRENYLTRANSFERASE INHIBITORS: DIVERSE STRUCTURAL CLASSES AND SURPRISING ANTI-CANCER MECHANISMS.CURRENT MEDICINAL CHEMISTRY. VOL. 8. ISSUE 12. P. 1437 -1465 | 169 | 87% | 30 |
Classes with closest relation at Level 2 |